Skip to main content
Premium Trial:

Request an Annual Quote

Agena Bioscience Gets FDA Emergency Use Authorization for MassArray Coronavirus Test

NEW YORK — Agena Bioscience on Monday received Emergency Use Authorization from the US Food and Drug Administration for its MassArray SARS-CoV-2 Panel.

The RT-PCR/MALDI-TOF test comprises five assays designed to detect the N, ORF1, and ORF1ab regions of the SARS-CoV-2 genome in upper respiratory specimens such as nasopharyngeal and oropharyngeal swabs, as well as bronchoalveolar lavage specimens.

RNA extraction is performed using Thermo Fisher Scientific's KingFisher Flex Purification System with Omega Bio-Tek's Mag-Bind Viral RNA Xpress Kit. Following PCR amplification on an authorized RT-PCR instrument, a sequence-specific primer extension step is performed using Agena's iPlex Pro reagents. Extension products are then transferred to Agena's SpectroChip Array for analysis on the company's MassArray mass spectrometry analyzer.

The test may be used by any lab CLIA-certified to perform high-complexity tests, according to the FDA.

"Agena proactively sourced and secured materials to provide uninterrupted product availability to our customers," Jason Halsey, Agena's senior VP of technology and operations, said in a statement. The "MassArray SARS-CoV-2 Panel kits and instruments are ready for immediate deployment, and we are equipped to supply millions of tests each month."

San Diego-based Agena said that thousands of samples can be processed in a day for less than $10 apiece on the MassArray instrument.

In addition to Agena's test, the MassArray system is used with authorized SARS-CoV-2 tests from the National Jewish Health Advanced Diagnostics Laboratory and Ethos Laboratories


The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.